Westminster Homecare has been acquired by Care at Home
The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.
Westminster Homecare is a specialist provider of care services to the elderly and young adults. It operates a network of branches throughout London and the South of England delivering care services to over 3,500 service users, enabling them to remain independent in their homes for longer.
Care at Home is a privately owned, independent family business providing a range of care services to clients in their own homes, under several brands including Care at Home Services, Beech Tree Total Care, Domus Live-In Care, and now Westminster Homecare. Care at Home partnered with ThinCats, an alternative lender that provides loans to mid-sized UK businesses, to help fund the transaction.
Oaklins Evelyn Partners, based in the UK, worked with the shareholders of Westminster Homecare to deliver a successful sale to a strategic partner. Combined, the group will be one of the largest providers of homecare services, with over 3,700 staff operating from 28 branches delivering homecare to the community and also care in 18 extra care facilities.
Sushil Radia
CEO, Westminster Homecare Ltd.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more